MedTrace Logo

EMS Combined With Resistance Training in Weight Lifters

NCT07484646 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-03-20

No results posted yet for this study

Summary

The purpose of this randomized controlled trial is to determine the effects of Electrical Muscle Stimulation (EMS) combined with resistance training on muscle mass, muscular strength, body composition, and power in trained weightlifters. Participants will be randomly allocated into two groups: one receiving resistance training alone and the other receiving EMS combined with resistance training. The intervention will be conducted for eight weeks, and outcome measures will be assessed at baseline, mid-intervention (4 weeks), and post-intervention (8 weeks). The findings of this study may provide evidence regarding the additional benefits of EMS when combined with conventional resistance training programs in enhancing muscular performance among trained athletes.

Conditions

  • Body Composition
  • Muscle Mass
  • Muscle Strength

Interventions

OTHER

EMS + Resistance Training

This group will combine the benefits of both EMS and Resistance Training to maximize muscle mass, strength, and body composition improvements using both EMS and RT (18). EMS will be applied to muscles using a frequency-specific protocol. EMS treatment according to the parameters defined as frequency (85 Hz), pulse duration (400 1s), and the duty cycle (10s on: 50s off). Exercises: A complementary schedule of EMS and resistance exercises. Frequency: 3 times per week (Tuesday, Thursday, Saturday) for 8 weeks.

OTHER

Resistance Training Only

This protocol will emphasize muscle strengthening through resistance training to improve strength and muscle mass through traditional resistance training methods (7). Exercises: A selection of exercises focusing on muscle mass and strength. Compound exercises (such as squats, deadlifts, bench press) and isolation exercises (such as bicep curls, triceps extensions) Frequency: 3 times per week (Monday, Wednesday, Friday) for 8 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Aifa Zeenat, MS* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-08-01
Completion
2026-09-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07484646 on ClinicalTrials.gov